InsightfulValue
← Home

Daiichi Sankyo
Daiichi Sankyo

-4.06%

Pharma / Pharmaceuticals, Biotechnology


πŸ”§ Tools

βœ… Due Diligence
Company at a Glance

Daiichi Sankyo

πŸ“Š Get full analytics about Daiichi Sankyo

Sign up for free or log in

✍️ Sign up to get "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" for free

Price
Live  
Overview
and its operations
Daiichi Sankyo is a global pharmaceutical company based in Japan. It was founded in 2005 through the merger of two Japanese pharmaceutical companies, Daiichi Pharmaceutical and Sankyo Co., Ltd. The company's global headquarters is located in Tokyo, Japan, and it has several research and development sites in Japan, Germany, and the United States.
Daiichi Sankyo is primarily focused on the development of innovative medicines for the treatment of cardiovascular, metabolic, and infectious diseases, as well as oncology. The company also has a strong presence in the over-the-counter and generic drug markets.
Daiichi Sankyo operates in more than 20 countries worldwide and has a diverse portfolio of drugs marketed in over 60 countries. The company's global sales in the fiscal year 2020 were approximately 950 billion yen (about $8.8 billion USD).
In addition to developing and marketing drugs, Daiichi Sankyo is also actively engaged in research and development collaborations with academic institutions and other pharmaceutical companies. The company's goal is to continue expanding its portfolio and delivering innovative treatment options to patients around the world.
Some of Daiichi Sankyo's notable drugs include:
- LIXIANA (rivaroxaban), an oral anticoagulant used to prevent and treat blood clots
- Thromboreductin (tenecteplase), a clot-dissolving enzyme used to treat heart attacks
- EVISTA (raloxifene), a selective estrogen receptor modulator used to treat osteoporosis and reduce the risk of developing breast cancer
- RECLAST (zoledronic acid), an intravenous medication used to treat osteoporosis and prevent bone fractures
- Benicar (olmesartan medoxomil), a blood pressure medication used to treat hypertension
- Oncology drugs, including ENHERTU (trastuzumab deruxtecan), for the treatment of HER2-positive breast and gastric cancer, and pexidartinib, for the treatment of certain types of tumors.
What is special about the company?
Daiichi Sankyo

πŸ“ˆ Want to read more about Daiichi Sankyo?

Sign up for free or log in

🎁 Free download! "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

MS4gUGlvbm VlcmluZyBQ aGFybWFjZX V0aWNhbCBD b21wYW55Oi BEYWlpY2hp IFNhbmt5by BpcyBhIGds b2JhbCBwaG FybWFjZXV0 aWNhbCBjb2 1wYW55IHRo YXQgaGFzIG JlZW4gaW4g b3BlcmF0aW 9uIGZvciBv dmVyIDEwMC B5ZWFycy4g SXQgaGFzIG Egc3Ryb25n IHRyYWNrIH JlY29yZCBv ZiBkZXZlbG 9waW5nIGlu bm92YXRpdm UgbWVkaWNp bmVzIGFuZC B0cmVhdG1l bnRzIGZvci B2YXJpb3Vz IGRpc2Vhc2 VzIGFuZCBj b25kaXRpb2 5zLjxicj4y LiBHbG9iYW wgUHJlc2Vu Y2U6IFRoZS Bjb21wYW55 IGhhcyBhIH N0cm9uZyBp bnRlcm5hdG lvbmFsIHBy ZXNlbmNlLC B3aXRoIG9w ZXJhdGlvbn MgaW4gbW9y ZSB0aGFuID UwIGNvdW50 cmllcyB3b3 JsZHdpZGUu IEl0IGhhcy BhIHdpZGUg bmV0d29yay BvZiByZXNl YXJjaCwgZG V2ZWxvcG1l bnQsIGFuZC BtYW51ZmFj dHVyaW5nIG ZhY2lsaXRp ZXMgaW4gQX NpYSwgRXVy b3BlLCBhbm QgTm9ydGgg QW1lcmljYS 48YnI+My4g Rm9jdXNlZC BvbiBLZXkg VGhlcmFwZX V0aWMgQXJl YXM6IERhaW ljaGkgU2Fu a3lvIGlzIG ZvY3VzZWQg b24gZGV2ZW xvcGluZyB0 cmVhdG1lbn RzIGluIGEg ZmV3IGtleS B0aGVyYXBl dXRpYyBhcm VhcywgbmFt ZWx5IGNhcm Rpb3Zhc2N1 bGFyIGRpc2 Vhc2UsIG9u Y29sb2d5LC BwYWluIG1h bmFnZW1lbn QsIGFuZCBp bW11bmUgZG lzb3JkZXJz LiBUaGlzIG FsbG93cyB0 aGUgY29tcG FueSB0byBj b25jZW50cm F0ZSBpdHMg cmVzb3VyY2 VzIGFuZCBl eHBlcnRpc2 Ugb24gZGV2 ZWxvcGluZy BlZmZlY3Rp dmUgdHJlYX RtZW50cyBp biB0aGVzZS BhcmVhcy48 YnI+NC4gQ2 9tbWl0bWVu dCB0byBSZX NlYXJjaCBh bmQgRGV2ZW xvcG1lbnQ6 IFRoZSBjb2 1wYW55IGlu dmVzdHMgYS BzaWduaWZp Y2FudCBwb3 J0aW9uIG9m IGl0cyByZX ZlbnVlIGlu dG8gcmVzZW FyY2ggYW5k IGRldmVsb3 BtZW50LCB3 aXRoIGEgc3 Ryb25nIGZv Y3VzIG9uIG RldmVsb3Bp bmcgaW5ub3 ZhdGl2ZSB0 cmVhdG1lbn RzLiBUaGlz IGNvbW1pdG 1lbnQgdG8g UiZEIGhhcy BoZWxwZWQg dGhlbSB0by BicmluZyBt YW55IGxpZm Utc2F2aW5n IGFuZCBsaW ZlLWVuaGFu Y2luZyBtZW RpY2luZXMg dG8gcGF0aW VudHMgd29y bGR3aWRlLj xicj41LiBD b2xsYWJvcm F0aXZlIEFw cHJvYWNoOi BEYWlpY2hp IFNhbmt5by BlbWJyYWNl cyBhIGNvbG xhYm9yYXRp dmUgYXBwcm 9hY2ggdG8g cmVzZWFyY2 ggYW5kIGRl dmVsb3BtZW 50LCBwYXJ0 bmVyaW5nIH dpdGggb3Ro ZXIgY29tcG FuaWVzLCBy ZXNlYXJjaC BpbnN0aXR1 dGlvbnMsIG FuZCBhY2Fk ZW1pYyBjZW 50ZXJzIHRv IGJyaW5nIG l0cyBtZWRp Y2luZXMgdG 8gbWFya2V0 LiBUaGlzIG NvbGxhYm9y YXRpb24gaG VscHMgdG8g YWNjZWxlcm F0ZSB0aGUg ZGV2ZWxvcG 1lbnQgb2Yg bmV3IGRydW dzIGFuZCB0 cmVhdG1lbn RzLjxicj42 LiBTdHJvbm cgUGlwZWxp bmU6IFRoZS Bjb21wYW55 IGhhcyBhIH JvYnVzdCBw aXBlbGluZS BvZiBpbm5v dmF0aXZlIG 1lZGljaW5l cyBpbiB2YX Jpb3VzIHN0 YWdlcyBvZi BkZXZlbG9w bWVudCwgcH JvdmlkaW5n IGEgc3Ryb2 5nIGZvdW5k YXRpb24gZm 9yIGZ1dHVy ZSBncm93dG ggYW5kIGV4 cGFuc2lvbi 48YnI+Ny4g Q29ycG9yYX RlIFNvY2lh bCBSZXNwb2 5zaWJpbGl0 eTogRGFpaW NoaSBTYW5r eW8gaXMgY2 9tbWl0dGVk IHRvIGNvcn BvcmF0ZSBz b2NpYWwgcm VzcG9uc2li aWxpdHkgYW 5kIHN1c3Rh aW5hYmlsaX R5LCB3aXRo IGEgZm9jdX Mgb24gZXRo aWNhbCBidX NpbmVzcyBw cmFjdGljZX MsIGVtcGxv eWVlIHdlbG wtYmVpbmcs IGFuZCBzb2 NpYWwgYW5k IGVudmlyb2 5tZW50YWwg aW5pdGlhdG l2ZXMuPGJy PjguIFBhdG llbnQtQ2Vu dGVyZWQgQX Bwcm9hY2g6 IFRoZSBjb2 1wYW55J3Mg bWlzc2lvbi BpcyB0byBz dHJpdmUgZm 9yIHRoZSAi Y3JlYXRpb2 4gb2YgbmV3 IGhlYWx0aG NhcmUgZnJv bnRpZXJzIi B0aHJvdWdo IHRoZSBkZX ZlbG9wbWVu dCBvZiBpbm 5vdmF0aXZl IG1lZGljaW 5lcyB0aGF0 IG1lZXQgdG hlIG5lZWRz IGFuZCBpbX Byb3ZlIHRo ZSBxdWFsaX R5IG9mIGxp ZmUgb2YgcG F0aWVudHMg d29ybGR3aW RlLjxicj45 LiBEaXZlcn NpZmllZCBQ b3J0Zm9saW 86IEluIGFk ZGl0aW9uIH RvIGl0cyBw aGFybWFjZX V0aWNhbCBi dXNpbmVzcy wgRGFpaWNo aSBTYW5reW 8gYWxzbyBo YXMgYSBwcm VzZW5jZSBp biBvdGhlci BoZWFsdGhj YXJlIHNlY3 RvcnMsIGlu Y2x1ZGluZy BvdmVyLXRo ZS1jb3VudG VyIG1lZGlj YXRpb25zLC BtZWRpY2Fs IGRldmljZX MsIGFuZCBk aWFnbm9zdG ljcywgcHJv dmlkaW5nIG EgZGl2ZXJz aWZpZWQgcG 9ydGZvbGlv IG9mIHByb2 R1Y3RzIGFu ZCBzZXJ2aW Nlcy48YnI+ MTAuIFN0cm 9uZyBNYW5h Z2VtZW50IF RlYW06IFRo ZSBjb21wYW 55IGhhcyBh IHN0cm9uZy BhbmQgZXhw ZXJpZW5jZW QgbWFuYWdl bWVudCB0ZW FtIHdpdGgg YSBwcm92ZW 4gdHJhY2sg cmVjb3JkIG 9mIHN1Y2Nl c3MgaW4gdG hlIHBoYXJt YWNldXRpY2 FsIGluZHVz dHJ5LCBlbn N1cmluZyB0 aGUgY29tcG FueSdzIHN0 cm9uZyBwZX Jmb3JtYW5j ZSBhbmQgbG 9uZy10ZXJt IHN1c3RhaW 5hYmlsaXR5 Lg==
What the company's business model?
Daiichi Sankyo

πŸ“ˆ Want to read more about Daiichi Sankyo?

Sign up for free or log in

πŸ™Œ Join now to get "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" at no cost

RGFpaWNoaS BTYW5reW8g aXMgYSBnbG 9iYWwgcGhh cm1hY2V1dG ljYWwgY29t cGFueSB0aG F0IGZvY3Vz ZXMgb24gdG hlIHJlc2Vh cmNoLCBkZX ZlbG9wbWVu dCwgYW5kIG 1hbnVmYWN0 dXJlIG9mIG lubm92YXRp dmUgbWVkaW NpbmVzLiBU aGVpciBidX NpbmVzcyBt b2RlbCByZX ZvbHZlcyBh cm91bmQgZG V2ZWxvcGlu ZyBhbmQgY2 9tbWVyY2lh bGl6aW5nIG 5ldyBhbmQg aW1wcm92ZW QgdHJlYXRt ZW50cyB0by BhZGRyZXNz IHVubWV0IG 1lZGljYWwg bmVlZHMuPG JyPlRoZSBj b21wYW55J3 MgY29yZSBi dXNpbmVzcy BzdHJhdGVn eSBpcyBidW lsdCBvbiB0 aHJlZSBrZX kgcGlsbGFy czogPGJyPj EuIElubm92 YXRpb246IE RhaWljaGkg U2Fua3lvIG ludmVzdHMg aGVhdmlseS BpbiByZXNl YXJjaCBhbm QgZGV2ZWxv cG1lbnQgKF ImRCkgdG8g ZGlzY292ZX IgYW5kIGRl dmVsb3Agbm V3IG1lZGlj aW5lcyBhY3 Jvc3MgYSBy YW5nZSBvZi B0aGVyYXBl dXRpYyBhcm VhcywgaW5j bHVkaW5nIG NhcmRpb3Zh c2N1bGFyLC BvbmNvbG9n eSwgYW5kIH JhcmUgZGlz ZWFzZXMuIF RoZSBjb21w YW55IGhhcy BhIGxhcmdl IGdsb2JhbC BSJkQgbmV0 d29yaywgaW 5jbHVkaW5n IHBhcnRuZX JzaGlwcyBh bmQgY29sbG Fib3JhdGlv bnMgd2l0aC BsZWFkaW5n IHVuaXZlcn NpdGllcyBh bmQgcmVzZW FyY2ggaW5z dGl0dXRpb2 5zLjxicj4y LiBHcm93dG g6IFRoZSBj b21wYW554o CZcyBncm93 dGggc3RyYX RlZ3kgaXMg Y2VudGVyZW Qgb24gZXhw YW5kaW5nIG l0cyBnbG9i YWwgcHJlc2 VuY2UgYW5k IHBvcnRmb2 xpbyB0aHJv dWdoIHN0cm F0ZWdpYyBw YXJ0bmVyc2 hpcHMsIGFs bGlhbmNlcy wgYW5kIGFj cXVpc2l0aW 9ucy4gVGhp cyBhbGxvd3 MgRGFpaWNo aSBTYW5reW 8gdG8gYWNj ZXNzIG5ldy BtYXJrZXRz LCB0ZWNobm 9sb2dpZXMs IGFuZCB0aG VyYXBpZXMs IGFzIHdlbG wgYXMgZGl2 ZXJzaWZ5IG l0cyBwcm9k dWN0IG9mZm VyaW5ncy48 YnI+My4gUm VzcG9uc2li aWxpdHk6IE RhaWljaGkg U2Fua3lvIG hhcyBhIHN0 cm9uZyBjb2 1taXRtZW50 IHRvIGV0aG ljYWwgYW5k IHNvY2lhbG x5IHJlc3Bv bnNpYmxlIG J1c2luZXNz IHByYWN0aW Nlcy4gVGhp cyBpbmNsdW RlcyBjb25k dWN0aW5nIG FsbCBidXNp bmVzcyBhY3 Rpdml0aWVz IHdpdGggaW 50ZWdyaXR5 IGFuZCB0cm Fuc3BhcmVu Y3ksIGFzIH dlbGwgYXMg c3VwcG9ydG luZyBpbml0 aWF0aXZlcy B0byBpbXBy b3ZlIGFjY2 VzcyB0byBo ZWFsdGhjYX JlIGFuZCBh ZGRyZXNzIG dsb2JhbCBo ZWFsdGggY2 hhbGxlbmdl cy48YnI+T3 ZlcmFsbCwg RGFpaWNoaS BTYW5reW8n cyBidXNpbm VzcyBtb2Rl bCBmb2N1c2 VzIG9uIGNv bnRpbnVhbG x5IGludmVz dGluZyBpbi BSJkQgYW5k IHN0cmF0ZW dpYyBncm93 dGggb3Bwb3 J0dW5pdGll cyB0byBkcm l2ZSBpbm5v dmF0aW9uIG FuZCBicmlu ZyBhZHZhbm NlZCBtZWRp Y2luZXMgdG 8gcGF0aWVu dHMgd29ybG R3aWRlLg==
Interesting facts about the company
Daiichi Sankyo

πŸ“ˆ Want to read more about Daiichi Sankyo?

Sign up for free or log in

πŸ’‘ Learn smarter stock picks with "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3MvZk pCNEZmczRM QUU1cG1TQ2 pkZ3Mud2Vi cCIgYWx0PS JEYWlpY2hp IFNhbmt5by IgdGl0bGU9 IkRhaWljaG kgU2Fua3lv IiAgY2xhc3 M9ImltZy1m bHVpZCIgaG VpZ2h0PTkw IHdpZHRoPT kwIGxvYWRp bmc9J2xhen knIHN0eWxl PSdib3JkZX ItcmFkaXVz OiA2cHg7Jz 4KCiAgICAg ICAgICAgIC AgICAgICAg PGRpdiBzdH lsZT0nZmxl eDogMTsgdG V4dC1hbGln bjogY2VudG VyOyBtYXJn aW4tbGVmdD ogNXB4Oyc+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgIDxwIHN0 eWxlPSdmb2 50LXNpemU6 IDI2cHg7IG NvbG9yOiAj MzMzOyBtYX JnaW4tYm90 dG9tOiAxNX B4Oyc+CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICDwn5OI IFdhbnQgdG 8gcmVhZCBt b3JlIGFib3 V0IERhaWlj aGkgU2Fua3 lvPwogICAg ICAgICAgIC AgICAgICAg ICAgICA8L3 A+CgogICAg ICAgICAgIC AgICAgICAg ICAgICA8YS BocmVmPSdp bmRleC5waH A/cGFnZT1z aWdudXAnIH N0eWxlPScK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIGJh Y2tncm91bm QtY29sb3I6 ICMwMDdCRk Y7CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Bjb2xvcjog I2ZmZjsKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIHBhZG Rpbmc6IDEw cHggMjBweD sKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIG JvcmRlci1y YWRpdXM6ID VweDsKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIHRleHQt ZGVjb3JhdG lvbjogbm9u ZTsKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IGZvbnQtd2 VpZ2h0OiBi b2xkOwogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgbWFyZ2 luLXJpZ2h0 OiAxMHB4Ow ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgdH JhbnNpdGlv bjogYmFja2 dyb3VuZC1j b2xvciAwLj NzIGVhc2U7 JwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg b25tb3VzZW 92ZXI9J3Ro aXMuc3R5bG UuYmFja2dy b3VuZENvbG 9yPSIjMDA1 NmIzIicKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIG9ubW 91c2VvdXQ9 J3RoaXMuc3 R5bGUuYmFj a2dyb3VuZE NvbG9yPSIj MDA3QkZGIi c+CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC BTaWduIHVw IGZvciBmcm VlCiAgICAg ICAgICAgIC AgICAgICAg ICAgIDwvYT 4KCiAgICAg ICAgICAgIC AgICAgICAg ICAgIDxzcG FuIHN0eWxl PSdtYXJnaW 46IDAgOHB4 OyBjb2xvcj ogIzU1NTsn Pm9yPC9zcG FuPgoKICAg ICAgICAgIC AgICAgICAg ICAgICAgPG EgaHJlZj0n aW5kZXgucG hwP3BhZ2U9 bG9naW4nIH N0eWxlPScK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIGNv bG9yOiAjMD A3QkZGOwog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgdGV4 dC1kZWNvcm F0aW9uOiB1 bmRlcmxpbm U7CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Bmb250LXdl aWdodDogNT AwOyc+CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBsb2cg aW4KICAgIC AgICAgICAg ICAgICAgIC AgICAgPC9h PgoKCiAgIC AgICAgICAg ICAgICAgIC AgICAgIDxw IHN0eWxlPS dtYXJnaW4t dG9wOiAxNX B4OyBmb250 LXNpemU6ID EzcHg7IGZv bnQtd2VpZ2 h0OiBib2xk OyBjb2xvcj ogI2QzMmYy ZjsnPgogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAg8J+TpS BHZXQgb3Vy IGZyZWUgZU Jvb2sgbm93 OiA8aT4iVG hlIENoZWNr bGlzdCBWYW x1ZSBJbnZl c3RvciDigJ QgQSBTbWFy dGVyIFdheS B0byBQaWNr IFN0b2Nrcy I8L2k+CiAg ICAgICAgIC AgICAgICAg ICAgICAgID wvcD4KCiAg ICAgICAgIC AgICAgICAg ICAgICAgID whLS0KICAg ICAgICAgIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nbWFyZ2 luLXRvcDog MTJweDsgZm 9udC1zaXpl OiAxM3B4Oy Bjb2xvcjog IzQ0NDsnPg ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgU2 lnbiB1cCBu b3cgYW5kIG dldCBvdXIg ZnJlZSBlQm 9vayAKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIDxiPlRo ZSBDaGVja2 xpc3QgVmFs dWUgSW52ZX N0b3Ig4oCU IEEgU21hcn RlciBXYXkg dG8gUGljay BTdG9ja3M8 L2I+CiAgIC AgICAgICAg ICAgICAgIC AgICAgIDwv ZGl2PgogIC AgICAgICAg ICAgICAgIC AgICAgICAt LT4KICAgIC AgICAgICAg ICAgICAgIC AgICAgPCEt LQogICAgIC AgICAgICAg ICAgICAgIC AgICA8ZGl2 IHN0eWxlPS dtYXJnaW4t dG9wOiAxNn B4OyBmb250 LXNpemU6ID E0cHg7IGNv bG9yOiAjND Q0OyBmb250 LWZhbWlseT ogLWFwcGxl LXN5c3RlbS wgQmxpbmtN YWNTeXN0ZW 1Gb250LCBT ZWdvZSBVSS wgUm9ib3Rv LCBIZWx2ZX RpY2EgTmV1 ZSwgc2Fucy 1zZXJpZjsg bGluZS1oZW lnaHQ6IDEu NjsnPgogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgSGF2ZS B5b3UgaGVh cmQgYWJvdX Qgb3VyIHNo b3J0IDxzdH Jvbmcgc3R5 bGU9J2Zvbn Qtd2VpZ2h0 OiA2MDA7Jz 5EYWlseSBW aWRlbyBOZX dzbGV0dGVy PC9zdHJvbm c+PwogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgPGEgaHJl Zj0naHR0cH M6Ly93d3cu aW5zaWdodG Z1bHZhbHVl LmNvbS9uZX dzbGV0dGVy LnBocCcgdG FyZ2V0PSdf YmxhbmsnIH N0eWxlPSdj b2xvcjogIz AwN0JGRjsg dGV4dC1kZW NvcmF0aW9u OiBub25lOy Bmb250LXdl aWdodDogNT AwOyBtYXJn aW4tbGVmdD ogNnB4Oyc+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgRmluZC BvdXQgbW9y ZQogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg PC9hPgogIC AgICAgICAg ICAgICAgIC AgICAgICA8 L2Rpdj4KIC AgICAgICAg ICAgICAgIC AgICAgICAg LS0+CiAgIC AgICAgICAg ICAgICAgIC AgPC9kaXY+ CiAgICAgIC AgICAgICAg ICA8L2Rpdj 4KICAgICAg ICAgICAgPC 9kaXY+CiAg ICAgICAgIC AgIAogICAg ICAgIAogIC AgICAgIDxz cGFuIGNsYX NzPSdibHVy cmVkLXRleH QnPgogICAg ICAgICAgIC BNUzRnUkdG cGFXIE5vYV NCVFlXNXIg ZVc4Z1EyOX RjRyBGdWVT d2dUR2x0IG FYUmxaQ0Jw Y3kgQmhJR2 RzYjJKaCBi Q0J3YUdGeW JXIEZqWlhW MGFXTmggYk NCamIyMXdZ VyA1NUlIZH BkR2dnIGFY UnpJR2hsWV cgUnhkV0Z5 ZEdWeSBjeU JzYjJOaGRH IFZrSUdsdU lGUnYgYTNs dkxDQktZWC BCaGJpNGdT WFFnIGQyRn pJR1p2ZFcg NWtaV1FnYV c0ZyBNakF3 TlNCMGFIIE p2ZFdkb0lI Um8gWlNCdF pYSm5aWCBJ Z2IyWWdkSG R2IElFcGhj R0Z1WlggTm xJSEJvWVhK dCBZV05sZF hScFkyIEZz SUdOdmJYQm ggYm1sbGN5 d2dSRyBGcG FXTm9hU0JR IGFHRnliV0 ZqWlggVjBh V05oYkNCaC BibVFnVTJG dWEzIGx2SU VOdkxpd2cg VEhSa0xqeG ljaiA0eUxp QlVhR1VnIG JtRnRaU0JF WVcgbHBZMm hwSUZOaCBi bXQ1YnlCMG NtIEZ1YzJ4 aGRHVnogSU hSdklIUm9a UyBCbWFYSn pkQ0IwIGFI SmxaU0IyYV ggSjBkV1Z6 SUdsdSBJRV Z1WjJ4cGMy IGdzSUhkb2 FXTm8gSUhO NWJXSnZiRy BsNlpYTWdk R2hsIElHTn ZiWEJoYm4g bmlnSmx6SU dOdiBiVzFw ZEcxbGJuIF FnZEc4Z1oy OXYgWkNCb1 pXRnNkRyBn c0lHbHVibT kyIFlYUnBk bVVnYVcgUm xZWE1zSUdG dSBaQ0J6Yj JOcFlXIHdn WTI5dWMyTn AgYjNWemJt VnpjeSA0OF luSStNeTRn IFJHRnBhV0 5vYVMgQlRZ VzVyZVc4Zy BhR0Z6SUdF Z1pHIGwyWl hKelpTQncg YjNKMFptOX NhVyA4Z2Iy WWdjSEpsIG MyTnlhWEIw YVcgOXVJRz FsWkdsaiBh VzVsY3l3Z1 ptIDlqZFhO cGJtY2cgYj I0Z1lYSmxZ WCBNZ2MzVm phQ0JoIGN5 QmpZWEprYV cgOTJZWE5q ZFd4aCBjaX dnYjI1amIy IHh2WjNrc0 lHRnUgWkNC d1lXbHVJRy AxaGJtRm5a VzFsIGJuUX VJRlJvWlgg a2dZWEpsSU dGcyBjMjhn YVc1MmIyIH gyWldRZ2FX NGcgZEdobE lHUmxkbSBW c2IzQnRaVz UwIElHOW1J SFpoWTIgTn BibVZ6SUdG dSBaQ0JpYV c5c2IyIGRw WTNNdVBHSn kgUGpRdUlF UmhhVyBsam FHa2dVMkZ1 IGEzbHZJR2 hoY3kgQmhJ SE4wY205dS BaeUJ3Y21W elpXIDVqWl NCcGJpQkIg YzJsaExDQj NhWCBSb0lH OTJaWElnIE 1qWWxJRzlt SUcgbDBjeU J6WVd4bCBj eUJqYjIxcG JtIGNnWm5K dmJTQjAgYU dseklISmxa MiBsdmJpNG dTWFFnIFlX eHpieUJvWV ggTWdiM0Js Y21GMCBhVz l1Y3lCcGJp IEJPYjNKMG FDQkIgYldW eWFXTmhMQy BCRmRYSnZj R1VzIElHRn VaQ0J2ZEcg aGxjaUJ3WV hKMCBjeUJ2 WmlCMGFHIF VnZDI5eWJH UXUgUEdKeV BqVXVJRSBs dUlESXdNRF lzIElFUmhh V2xqYUcga2 dVMkZ1YTNs diBJR0ZqY1 hWcGNtIFZr SUdFZ2JXRn EgYjNKcGRI a2djMyBSaG EyVWdLRFkw IEpTa2dhVz RnU1cgNWth V0Z1SUdkbC BibVZ5YVdN Z2NHIGhoY2 0xaFkyVjEg ZEdsallXd2 dZMiA5dGNH RnVlU0JTIF lXNWlZWGg1 SUUgeGhZbT l5WVhSdiBj bWxsY3k0Z1 ZHIGhsSUdG amNYVnAgYz JsMGFXOXVJ RyBGc2JHOT NaV1FnIFJH RnBhV05vYV MgQlRZVzVy ZVc4ZyBkRz hnWlhod1lX IDVrSUdsMG N5QnkgWldG amFDQnBiaS BCbGJXVnla Mmx1IFp5Qn RZWEpyWlgg UnpManhpY2 o0MiBMaUJV YUdVZ1kyID l0Y0dGdWVT QnAgY3lCam IyMXRhWCBS MFpXUWdkRz hnIGMzVnpk R0ZwYm0gRm lhV3hwZEhr ZyBZVzVrSU doaGN5IEJw YlhCc1pXMW wgYm5SbFpD QjJZWCBKcG IzVnpJR2x1 IGFYUnBZWF JwZG0gVnpJ SFJ2SUhKbC BaSFZqWlNC cGRIIE1nWl c1MmFYSnYg Ym0xbGJuUm hiQyBCcGJY QmhZM1FzIE lITjFZMmdn WVggTWdjbV ZrZFdOcCBi bWNnWTJGeV ltIDl1SUdW dGFYTnogYV c5dWN5Qmhi bSBRZ2NISn ZiVzkwIGFX NW5JR2R5Wl cgVnVJSEJ5 YjJOMSBjbV Z0Wlc1MExq IHhpY2o0M0 xpQkUgWVds cFkyaHBJRi BOaGJtdDVi eUJvIFlYTW dZU0J6ZEgg SnZibWNnWm 05aiBkWE1n YjI0Z2NtIF Z6WldGeVky Z2cgWVc1a0 lHUmxkbSBW c2IzQnRaVz UwIElDaFNK a1FwTEMgQj NhWFJvSUc5 MiBaWElnWV NCeGRXIEZ5 ZEdWeUlHOW 0gSUdsMGN5 QmxiWCBCc2 IzbGxaWE1n IFpHVmthV0 5oZEcgVmtJ SFJ2SUhSby BhWE1nWVhK bFlTIDRnVk dobGVTQm8g WVhabElGSW 1SQyBCbVlX TnBiR2wwIG FXVnpJR2x1 SUUgcGhjR0 Z1TENCSCBa WEp0WVc1NU xDIEJoYm1R Z2RHaGwgSU ZWdWFYUmxa QyBCVGRHRj BaWE1zIElH RnRiMjVuSU cgOTBhR1Z5 SUdOdiBkVz UwY21sbGN5 IDQ4WW5JK0 9DNGcgU1c0 Z01qQXhNeS B3Z1JHRnBh V05vIGFTQl RZVzVyZVcg OGdjbVZqWl dsMiBaV1Fn WVhCd2NtID kyWVd3Z1pt OXkgSUdsMG N5Qm1hWCBK emRDQmhibl JwIFltOWtl UzFrY24gVm 5JR052Ym1w MSBaMkYwWl NBb1FVIFJE S1NCd2NtOW sgZFdOMExD QjNhRyBsam FDQmpiMjFp IGFXNWxjeU JoYmkgQmhi blJwWW05ay BlU0JoYm1R Z1lTIEJqYU dWdGIzUm8g WlhKaGNIa2 daSCBKMVp5 QjBieUIwIF lYSm5aWFJs WkMgQmpZVz VqWlhJZyBZ MlZzYkhNZ1 lXIDVrSUcx cGJtbHQgYV hwbElHUmhi VyBGblpTQj BieUJvIFpX RnNkR2g1SU cgTmxiR3h6 TGp4aSBjaj Q1TGlCVWFH IFVnWTI5dG NHRnUgZVNC b1lYTWdZUy BCemRISnZi bWNnIFkyOX RiV2wwYlcg VnVkQ0IwYn lCdyBhR2xz WVc1MGFIIE p2Y0hrZ1lX NWsgSUdoaG N5QnpaWCBR Z2RYQWdkR2 hsIElFUmhh V2xqYUcga2 dVMkZ1YTNs diBJRVp2ZF c1a1lYIFJw YjI0Z2IyWW cgVEdsbVpT QlRZMiBsbG JtTmxJSFJ2 IElITjFjSE J2Y24gUWdj bVZ6WldGeS BZMmdnWVc1 a0lHIFZrZF dOaGRHbHYg YmlCcGJpQj BhRyBVZ2JH bG1aU0J6IF kybGxibU5s Y3kgQm1hV1 ZzWkM0OCBZ bkkrTVRBdU lFIEZ6SUc5 bUlESXcgTW pFc0lFUmhh VyBsamFHa2 dVMkZ1IGEz bHZJR2hoWk MgQnZkbVZ5 SURFMiBMRE F3TUNCbGJY IEJzYjNsbF pYTWcgZDI5 eWJHUjNhVy BSbElHRnVa Q0JuIFpXNW xjbUYwWlcg UWdiM1psY2 lBayBPQ0Jp YVd4c2FXID l1SUdsdUlI SmwgZG1WdW RXVXVJRSBs MElHbHpJSE poIGJtdGxa Q0JoYlcgOX VaeUIwYUdV ZyBkRzl3SU RJd0lIIEJv WVhKdFlXTm wgZFhScFky RnNJRyBOdm JYQmhibWxs IGN5Qm5iRz lpWVcgeHNl UzQ9CiAgIC AgICAgPC9z cGFuPgogIC AgICAgIAog ICAgICAgIA ==
See Company Q&A
Daiichi Sankyo

πŸ“Š Get full analytics about Daiichi Sankyo

Sign up for free or log in

πŸ“˜ Claim your free eBook: "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

© 2024 - 2025 InsightfulValue.com. All rights reserved. Newsletter
Legal